In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The closing price of Conmed Corp (NYSE: CNMD) was $50.01 for the day, down -2.74% from the previous closing price of $51.42. In other words, the price has decreased by -$2.74 from its previous closing price. On the day, 0.56 million shares were traded. CNMD stock price reached its highest trading level at $51.57 during the session, while it also had its lowest trading level at $49.735.
Ratios:
Our analysis of CNMD’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 45.61 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 10.44. For the most recent quarter (mrq), Quick Ratio is recorded 1.00 and its Current Ratio is at 2.23. In the meantime, Its Debt-to-Equity ratio is 0.88 whereas as Long-Term Debt/Eq ratio is at 0.88.
On April 28, 2025, Stifel Downgraded its rating to Hold which previously was Buy but kept the price unchanged to $55.
JP Morgan Downgraded its Overweight to Neutral on February 06, 2025, whereas the target price for the stock was revised from $85 to $70.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Sep 12 ’25 when Farkas Charles sold 2,000 shares for $53.52 per share. The transaction valued at 107,049 led to the insider holds 14,859 shares of the business.
Farkas Charles bought 2,000 shares of CNMD for $107,049 on Sep 12 ’25. On Aug 07 ’25, another insider, Garner Todd W, who serves as the Executive Vice President & CFO of the company, sold 598 shares for $52.45 each. As a result, the insider received 31,365 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CNMD now has a Market Capitalization of 1548057728 and an Enterprise Value of 2395947776. As of this moment, Conmed’s Price-to-Earnings (P/E) ratio for their current fiscal year is 14.12, and their Forward P/E ratio for the next fiscal year is 10.55. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.64. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.17 while its Price-to-Book (P/B) ratio in mrq is 1.54. Its current Enterprise Value per Revenue stands at 1.807 whereas that against EBITDA is 10.887.
Stock Price History:
The Beta on a monthly basis for CNMD is 1.17, which has changed by -0.3376159 over the last 52 weeks, in comparison to a change of 0.1653893 over the same period for the S&P500. Over the past 52 weeks, CNMD has reached a high of $78.00, while it has fallen to a 52-week low of $46.00. The 50-Day Moving Average of the stock is -4.30%, while the 200-Day Moving Average is calculated to be -14.97%.
Shares Statistics:
CNMD traded an average of 451.66K shares per day over the past three months and 359720 shares per day over the past ten days. A total of 30.95M shares are outstanding, with a floating share count of 30.07M. Insiders hold about 2.85% of the company’s shares, while institutions hold 111.21% stake in the company. Shares short for CNMD as of 1756425600 were 2089682 with a Short Ratio of 4.63, compared to 1753920000 on 2096118. Therefore, it implies a Short% of Shares Outstanding of 2089682 and a Short% of Float of 9.22.
Dividends & Splits
With its trailing 12-month dividend rate of 0.8, CNMD has a forward annual dividend rate of 0.80. Against a Trailing Annual Dividend Yield of 0.01555815. The stock’s 5-year Average Dividend Yield is 0.89. The current Payout Ratio is 18.82% for CNMD, which recently paid a dividend on 2025-09-15 with an ex-dividend date of 2025-09-15. Stock splits for the company last occurred on 2001-09-10 when the company split stock in a 3:2 ratio.
Earnings Estimates
Investors are keenly observing as 6.0 analysts analyze and rate. The current performance of Conmed Corp (CNMD) in the stock market.The consensus estimate for the next quarter is $1.32, with high estimates of $1.36 and low estimates of $1.27.
Analysts are recommending an EPS of between $4.5 and $4.43 for the fiscal current year, implying an average EPS of $4.47. EPS for the following year is $4.78, with 6.0 analysts recommending between $4.99 and $4.5.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 6 analysts. It ranges from a high estimate of $337.3M to a low estimate of $332.5M. As of. The current estimate, Conmed Corp’s year-ago sales were $316.7MFor the next quarter, 6 analysts are estimating revenue of $369.1M. There is a high estimate of $370.7M for the next quarter, whereas the lowest estimate is $367.69M.
A total of 6 analysts have provided revenue estimates for CNMD’s current fiscal year. The highest revenue estimate was $1.37B, while the lowest revenue estimate was $1.37B, resulting in an average revenue estimate of $1.37B. In the same quarter a year ago, actual revenue was $1.31BBased on 6 analysts’ estimates, the company’s revenue will be $1.44B in the next fiscal year. The high estimate is $1.46B and the low estimate is $1.42B.
